Should all patients with thyroid nodules ≥ 1 cm undergo fine-needle aspiration biopsy?;Soll man alle schilddrüsenknoten ≥ 1 cm punktieren?

NuklearMedizin

Volumn 48, Issue 3, 2009, Pages 79-83

  Schicha, Harald ^a   Hellmich, M ^a   Lehmacher, W ^a   Eschner, W ^a   Schmidt, M ^a   Kobe, C ^a   Schober, O ^b   Dietlein, M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Bayes theorem; Epidemiology; Fine needle aspiration cytology; Thyroid nodule

Indexed keywords

CALCITONIN; THYROGLOBULIN; THYROTROPIN;

ADULT; AGED; ALGORITHM; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; CYTOLOGY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; GENE MUTATION; HUMAN; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PATIENT SELECTION; PREVALENCE; PROBABILITY; SCINTIGRAPHY; THYROID CANCER; THYROID CELL; THYROID NODULE; THYROID SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BAYES THEOREM; BIOPSY, FINE-NEEDLE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROBABILITY; THYROID NODULE; THYROTROPIN; YOUNG ADULT;

EID: 67049166936     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0313     Document Type: Article

References (26)

1. Banks ND, Kowalski J, Tsai HL et al. A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 2008; 18: 933-941.
2. Chung KW, Yang SK, Lee GK et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cytopathology diagnosis, especially in BRAF600E mutation prevalent area. Clin Endocrinol 2006; 65: 660-666. (Pubitemid 44583829)
3. Cooper DS, Doherty GM, Haugen BR et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16: 109-141
4. Cronan JJ. Thyroid nodules: Is it time to turn off the US machines? Radiology 2008; 247: 602-604.
5. Dietlein M, Dressler J, Eschner W et al. Procedure guideline for thyroid scintigraphy (version 3). Nuklearmedizin 2007; 46: 203-205. (Pubitemid 47612286)
6. Dietlein M, Wieler H, Schmidt M et al. Routine measurement of serum calcitonin in patients with nodular thyroid disorders? Nuklearmedizin 2008; 47: 65-72.
7. Dietlein M, Wegscheider K, Vaupel R et al. Survey of management of solitary thyroid nodules in Germany . Nuklearmedizin 2008; 47: 87-96. (Pubitemid 351881402)
8. Dietlein M, Wegscheider K, Vaupel R et al. Management of multinodular goiter in Germany. Do the approaches of thyroid specialists and primary care practitioners differ? (Papillon 2005) Nuklearmedizin 2007; 41 : 65-75.
9. Gharib H, Papini E, Paschke R. Thyroid nodules: a review of current guidelines, practices, and prospects . Eur J Endocrinol 2008; 159: 493-505.
10. Jin L, Sebo TJ, Nakamura N et al. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol 2006; 15: 136-143. (Pubitemid 44325474)
11. Kim SK, Kim DL, Han HS et al. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol 2008; 17: 118-125.
12. Laurberg P, Pedersen KM, Vestergaard H, Sigurd - sson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 1991; 229: 415-420.
13. Luster M, Führer D, Engelhardt C et al. Prävalenz von szintigraphisch heißen, kalten und indifferenten Schilddrüsenknoten bei Patienten mit bekanntem solitärem Herdbefund. Nuklearmedizin 2005; 44: A6-A7.
14. Mazzaferri EL, Sipos J. Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and preoperative neck ultrasonography to define the extent of tumor invasion? Thyroid 2008; 18: 597-602.
15. Moon WJ, Jung SL, Lee JH et al. Benign and malignant thyroid nodules: US differentiation - multicenter retrospective study. Radiology 2008; 247: 762-770.
16. Pacini F, Schlumberger M, Dralle H et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787-803. (Pubitemid 43997716)
17. Perros P, Weightman DR. Role of serum thyroglobulin measurement in patients with thyroid nodules. Clin Endocrinol (Oxf) 2003; 59: 657. (Pubitemid 37357629)
18. Rahbar K, Hutzenlaub V, Fischer R-J et al. Risk-profile and outcome of small papillary and follicular thyroid carcinomas (≤1 cm). Nuklearmedizin 2008; 47: 188-193.
19. Reiners, C, Wegscheider K, Schicha H et al. Prevalence of thyroid disorders in the working population of Germany: Ultrasonography screening in 96 278 unselected employees. Thyroid 2004; 14: 926-932. (Pubitemid 39612911)
20. Riemann B, Schober O. Are "high-risk" patients with differentiated thyroid cancer "healthy patients"? Nuklearmedizin 2008; 47: 179-180.
21. Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg). Krebs in Deutschland 2003-2004. Häufigkeiten und Trends. 6. Auf. 86-89. Berlin 2008
22. 99mTc-MIBI SPECT in primary hyperparathyroidism. Influence of concomitant vitamin D deficiency for visualization of parathyroid adenomas. Nuklearmedizin 2008; 47: 1-7.
23. Schönberger J, Marienhagen J, Agha A et al. Papillary microcarcinoma and papillary cancer of the thyroid ≤1 cm. Modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin 2007; 46: 115-120.
24. Statistisches Bundesamt. Bevölkerung nach Altergruppen - Deutschland. Aktualisiert am 14. Oktober 2008. www.destatis.de
25. 201Tl scintigraphy in differentiating between benign and malignant thyroid follicular lesions. Ann Nucl Med 2002; 16: 95-101.
26. Völzke H, Lüdermann J, Robinson DM et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803-810. (Pubitemid 37070159)